Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Trastuzumab Injection

Approval Number

国药准字SJ20181017

CompanyRoche Pharma (Schweiz) AG

Registration Date

May 16, 2023

Previous Approval Numbers

S20181017

Drug Information

Generic Name

注射用曲妥珠单抗

Trade Name

赫赛汀

Dosage Form

注射剂

Strength

440mg(20ml)/瓶

Drug Type

生物制品

Registration Date

May 16, 2023

Expiry Date

May 15, 2028

Company Information

Applicant Company

Company NameRoche Pharma (Schweiz) AG

Company Address

Gartenstrasse 9,4052 Basel,Switzerland

Manufacturing Company

Company NameGENENTECH INC

Company Address

4625 NE Brookwood Parkway, Hillsboro, OR 97124-9332 USA

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy